Cardiac Drugs Flashcards

(34 cards)

1
Q

Furosemide

A

Loop Diuretic
MOA: Prevents passive reabsorption of water by blocking reabsorption of Na and Cl in the thick segment of the ascending loop of Henle.
Indications:
- Pulmonary edema (HF)
- Edema
- Uncontrolled HTN
Adverse Effects:
- Low Na, Cl, K, & BP
- Transient ototoxicity; increased risk with other ototox. meds
- Dehydration, with increased risk for thrombosis & emboli
- Ventricular dysrhythmias with dig. use
Nursing Considerations:
- Close I/O monitoring, VS, weight, hearing, and electrolytes
- Morning to early afternoon admin
- Slow IVP (10-20mg/min)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hydrochlorothiazide

A
Thiazide Diuretic
MOA: Prevents passive reabsorption of water by blocking reabsorption of Na and Cl in the early segment of the distal convoluted tubule.
Indications:
- Essential HTN
- Edema (r/t HF, hepatic, or renal disease)
- Diabetes insidipidus
- Postmenopausal osteoporosis
Adverse Effects:
- Low Na, Cl, K, & BP
- Dehydration
- Ventricular dysrhythmias if on dig.
Nursing Considerations:
- Do not use in patients with low GFR!
- Close I/O monitoring, VS, weight, and electrolytes
- Morning to early afternoon admin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Spironolactone

A

Potassium-sparing Diuretic
MOA: Blocks aldosterone effects in the distal nephron (DCT) to produce modest diuresis
Indications:
- Essential HTN, often co-admin. with potassium-wasting diuretics
- Edema
- HF
Adverse Effects:
- Hyperkalemia
Endocrine effects; menstrual irregularities, impotence, hirsutism, and deepened voice
Nursing Considerations:
- Close I/O monitoring, VS, weight, and electrolytes, particularly when taking ACE inhibitors, ARBs, and DRI
- Educate patient about potassium-rich dietary source

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mannitol

A

Osmotic diuretic
MOA: Creates osmotic force that inhibits passive reabsorption of water; also increases serum osmolarity to draw fluid back into vascular and extravascular space
Indications:
- Prophylaxis of renal failure with hypovolemic shock and severe hypotension
- Reduction of intracranial and intraocular pressure
Adverse Effects:
- Edema (in patients with existing HF)
- Fluid & electrolyte imbalances
Nursing Considerations:
- Use filter needles & IV tubing to prevent administering crystals
- Monitor for changes in ICP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lisinopril

A
ACE Inhibitor
MOA: Inhibits ACE & blocks effects of ang. II; increases levels of bradykinin to dilate blood vessels and reduce blood volume
Indications:
- HTN
- HF
- Post-MI Tx
- Prevention of MI, CVA, and death in patients with high CV risk
- Diabetic nephropathy
Adverse Effects:
- First-dose hypertension
- Cough (r/t bradykinin)
- Angioedema (r/t bradykinin)
- Hyperkalemia
- Fetal injury
Nursing Considerations:
- Monitor BP & electrolytes closely
- Educate patients to contact provider if cough and/or angioedema occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Losartan

A

Angiotensin II Receptor Blocker (ARB)
MOA: Blocks Ang. II receptors to produce vasodilation, prevent cardiac structural changes, and prevent aldosterone release
Indications:
- HTN
- Reduce risk of stroke, MI, and CV related death in high-risk patients
- Diabetic nephropathy & retinopathy
Adverse Effects:
- Angioedema (lower risk than ACEi)
- Fetal injury
Nursing Considerations:
- If ACEi not tolerated, ARBs given instead
- Monitor BP closely, especially if on multiple agents
- Educate patients to contact provider if angioedema occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aliskiren

A

Direct renin inhibitor
MOA: Binds with renin to inhibit cleavage of angiotensinogen into angiotensin I to reduce influence of entire RAAS
Indications:
- Hypertension
Adverse Effects:
- Generally well-tolerated
- Diarrhea
- Low risk of hyperkalemia, angioedema, and cough
- Fetal injury
Nursing Considerations:
- Close I/O monitoring, vital signs, weight, and electrolytes especially if on multiple antihypertensive agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hydralazine

A

Vasodilator
MOA: Causes selective dilation of arterioles through actions on vascular smooth muscle to reduce peripheral resistance and blood pressure
Indications:
- Essential HTN
- Hypertensive crisis
- HF
Adverse Effects:
- Reflex tachycardia
- Increased BV
- Systemic Lupus Erythmateus (SLE)-like syndrome (serositis, oral ulcers, arthritis, photosensitivity, blood counts low, renal damage, antinuclear antibody, immunologic disorder, neurologic disorder, malar rash, discoid rash; SOAP BRAIN MD)
Nursing Considerations:
- Combine with isosorbide denigrate when used for treatment of heart failure
Co-admin. with beta-blocker to reduce reflex achy
Co-admin. with diuretic to reduce risk of sodium and water retention
Monitor VS closely, especially for excessive hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nitroprusside

A

Vasodilator
MOA: Causes both venous and arteriolar dilation to decrease BP
Indications:
- DOC for hypertensive emergencies!
- Controlled hypotension during surgery to reduce bleeding
Adverse Effects:
- Excessive hypotension
- Cyanide poisoning most likely in patients with liver disease
- Thiocyanate toxicity
Nursing Considerations:
- Minimal reflex tachycardia
- Continuously monitor VS and ECG & reassess patients for s/s that reflect changes in BP
- Initial infusion rates range from 0.3-0.5 mcg/kg/min and titrated to slowly bring down BP
- Co-admin. with PO antihypertensives
Immediate effects trigger Na and water retention; manage with furosemide admin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Beta-Blockers (Metoprolol, Carvedilol, Lopressor, etc)

A

First-line tx for HF
Decreases contractility and allows ventricles to fill
Improves EF, exercise tolerance, and slows HF progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Vasodilators

A

PO: BiDil (Isosorbide/Hydralazine)
- Approved for specific ethnic group (African Americans)
IV Nitroglycerin (NTG)
- Decreases pulmonary edema and angina
- Adverse Effects: hypotension, reflex tachycardia, and headache
IV Nitroprusside:
- Fast acting, short-term severe HF tx
- DOC for hypertensive emergencies/crisis
- AE: profound hypotension!
IV Nesirtide
- Synthetic form of BNP
- Short-term use for very severe/decompensated HF
- AE: V-tach, headache, and hypotenion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Digoxin

A

Cardiac Glycoside
Indications:
- Treats symptomatic HF and A-fib; does not prolong life
- 2nd line tx for HF due to its toxicity & adverse effects
+ inotrope (increases contractility; - chronotrope (decreases HR); - dromotrope (decrease conduction)
Adverse Effects:
- Fatigue
- Blurred/yellow tinged vision
- Dysrhythmias (most serious AE)
Nursing Considerations:
- Co-administer with K+ supplements
Antidotes for Toxicity:
- Digoxin Immune Fab (Digibind/Digifab); onset < 1 min; improvement in 15-30 minutes
- Activated charcoal & cholestyramine (Questran); decreases GI absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Kayexalate

A
Hyperkalemia tx
MOA: Binds to K+ in large intestine and excreted in feces
Indications:
- Hyperkalemia
- Administered PO or enema
Adverse Effects:
- Gastric irrigation
- Nausea/Vomiting
- Constipation (Impaction)
- Hypokalemia
Nursing Considerations:
- Asses for bowel sounds/gastric motility prior to admin.
- Monitor EKG
- Monitor electrolytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Regular Insulin

A

Hyperkalemia Tx
MOA: Pushes K+ back into cell
- IV glucose plus 5-10 units of reg. insulin
- Reduces serum insulin level within 10-20 minutes
- Lasts 4-6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Class IA Antidysrhythmics (Sodium Channel Blockers)

A
Quinidine
- DOC for malaria
EKG changes: 
- Widens QRS/Prolong QT interval
Indications:
- A-fib/flutter
- Ventricular dysrhythmias (sustained V-tach)
- Torsades de pointes
Adverse Effects:
- Diarrhea
- Vasodilation/hypotension
Nursing Considerations:
- Interacts with digoxin! (Doubles levels)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Class IB Antidysrhythmics (Sodium Channel Blockers)

A
Lidocaine
EKG Changes:
- little/no effect
Indications:
- Ventricular dysrhythmias only
- Local anesthetic
Adverse Effects:
- CNS (confusion/drowsiness)
17
Q

Class IC Antidysrhythmics (Sodium Channel Blockers)

A
Flecainide 
EKG Changes:
- Widening QRS/PR Interval prolonged
Indications:
- Severe Ventricular dysrhythmias not responsive to other drugs
- A-fib/flutter post-cardioversion
18
Q

Class II Antidysrhythmics (Beta-Blockers)

A
Propanolol
EKG Changes: 
- Prolonged PR interval
Indications:
- Tachycardias (Sinus & recurrent VT)
- SVT Chemical Cardioversion
Adverse Effects:
- HF
- AV Block
- Hypotension
- Bronchospasm (if asthma hx)
19
Q

Class III Antidysrhythmics (Potassium Channel Blockers)

A

Amiodarone
EKG Changes:
- Widening QRS/Prolonged QT/PR Intervals
Indications:
- Ventricular dysrhythmias r/t toxicities
- A-fib/flutter post-cardioversion
Adverse Effects:
- Multiple severe organ toxicities
- Bluish-gray skin color from sun exposure
Nursing Considerations:
- Multiple drug interactions; digoxin/warfarin/statins; grapefruit juice increases levels

20
Q

Class IV Antidysrhythmics (Calcium Channel Blockers)

A
Verapamil/Diltiazem
MOA: Blocks Ca+ channels to the heart which decrease contractions, HR, and conduction velocity. Also, causes vasodilation
Indications:
- Dysrhythmias
- Angina
- Chronic HTN
Adverse Effects:
- Constipation
- Dizziness
- Pedal edema
- Bradycardia
Nursing Considerations:
- Contraindicated in HF!
- Digoxin & grapefruit juice increases toxicity!
- Administer BB several hours apart to avoid cardiac suppression
- Monitor VS, I/O, and daily weights!
21
Q

Nitroglycerin

A

MOA: Vasodilates BV & increases blood flow to obstructed areas.
Indications:
- DOC for acute angina
Adverse Effects:
- Headache
- Hypotension
- Reflex tachycardia
Nursing Considerations:
- Avoid EtOH, other hypotensive medications, and PDE5 meds (viagra)
- Remove TD patch for at least 8 hours a day to prevent tolerance

22
Q

Ranolazine

A

Antianginal

  • Modest effects
  • May prolong QT interval and cause ventricular dysrhythmia
  • Increases BP in those with renal impairment (monitor closely)
  • Several drug interactions
23
Q

Atorvastatin

A
HMG-CoA Reductase Inhibitor (STATINS)
MOA: Increases number of LDL receptors on hepatocytes
Indications:
- Hypercholesterolemia
- Primary and secondary CV prevention
- Post-MI tx
- Type II DM
Adverse Effects:
- Myopathy/Rhabdomyolysis
- Hepatotoxicity
- Teratogenicity
Nursing Considerations:
- Evening administration preferred 
- Monitor liver function & CK
- Patient education on contraception & myopathy
24
Q

Colsevelam

A

Bile acid sequestrant
MOA: Prevents reabsorption of bile acids by binding (sequestering) them when released into the small intestine
Indications:
- Adjunctive tx for hypercholesterolemia, often with statins
Adverse Effects:
- Only GI; constipation, bloating, indigestion, and nausea
Nursing Considerations:
- Can interact with other commonly used medications to decrease absorption, including thiazides, digoxin, and warfarin
- Administer other meds 1 hour before or 4 hours after
- Increase fluids & fiber prior to laxative use (last resort)

25
Gemfibrozil
``` Fibric acid derivative MOA: Activates PPAR alpha to accelerate clearance of VLDLs to reduce TG levels Indications: - Hypertriglyceridemia Adverse Effects: - Rash & GI most common - Gallstones - Myopathy/rhabdomyolysis - Hepatotoxicity Nursing Considerations: - Can increase anticoagulant effects in patients on warfarin; monitor for bleeding & INR! - Diet modification - Educate patient on myopathy - Administer 30 minutes before morning and evening meals ```
26
Aspirin
Antiplatelet medication MOA: Irreversibly inhibits cyclooxyrgenase to prevent TXA2 synthesis needed to promote platelet activation Indications: - CVA/TIA prevention - Angina/MI prevention Adverse Effects: - Bleeding - Salicylism (Aspirin poisoning; fever, n/v, dehydration, excitability, hyperventilation, etc.) Nursing Considerations: - Dosing 81mg for CV-event prevention/325mg initial CV-event treatment - Educate & monitor for signs of bleeding - Educate on other sources of aspirin to prevent OD (alkaseltzer, etc.) - Administer Proton-Pump Inhibitor (PPI) if bleeding occurs - Stop aspirin 7-10 days prior to surgery!
27
Clopidogrel
P2Y12 Adenosine Diphosphate (ADP) Receptor Antagonist MOA: Prevents platelet aggregation by blocking ADP receptors Indications: - Combined with aspirin tx, helps reduce thrombotic events in patients with ACS - Prevents blockage of coronary artery stents Adverse Effects: - Bleeding - Thrombotic Thrombocytopenic Purpura (TTP) Nursing Considerations: - Educate & monitor for signs of bleeding - Give PPI if GI bleeding occurs - Discontinue 7-10 days prior to surgery
28
Abciximab
``` Glycoprotein IIb/IIIa Receptor Antagonist MOA: Causes reversible blockade of platelet receptors to inhibit the final step of platelet aggregation Indications: - ACS - PCI Adverse Effects: - Bleeding, particularly at PCI site Nursing Considerations: - Post-procedure cardiac cath monitoring - Monitor for bleeding s/s ```
29
Heparin
Antithrombin activating anticoagulant MOA: Enhances the activity of antithrombin to indirectly inhibit activity of thrombin and factor Xa - Prevents NEW blood clots from GROWING, does not dissolve existing clots! Indications: - DVT/PE - Open heart surgery & renal dialysis DIC Anticoagulation during pregnancy Adverse Effects: - Bleeding - Heparin-Induced Thrombocytopenia (HIT) - Severe neurological injury if given to spine/epidural patients Nursing Considerations: - Educate & monitor for signs of bleeding - SubQ injection protocol; don't massage site! - Monitor aPTT & CBC during therapy - Protamine sulfate antidote! (neutralizes 100U)
30
Enoxaparin
Low-molecular weight heparin MOA: Enhances the activity of antithrombin to preferentially indirectly inhibit activity of thrombin factor Xa, with some inhibition on thrombin Indications: - DVT/PE - DVT prophylaxis following THA, TKA, & abdominal Sx - Off-label use for DVT prophylaxis following trauma/spinal Sx Adverse Effects: - Bleeding - Heparin-induced thrombocytopenia (HIT) - Severe neurological injury if given to spinal/epidural patients Nursing Considerations: - Educate & monitor for signs of bleeding - Monitor CBC during therapy - Caution with shaving; use only electric razors! - Protamine sulfate antidote!
31
Warfarin
Vitamin K Antagonist MOA: Suppresses production of clotting factors II, VII, IX, and X Indications: - Prevention of DVT/PE - Prevention of thromboembolism in patients with prothetic heart valves - Prevention of thrombosis in patients with atrial fibrillation Adverse Effects: - Bleeding (spontaneous) - Teratogenic Nursing Considerations: - Educate & monitor for signs of bleeding - Monitor PT & INR during therapy (INR 2.0-3.0 therapeutic) - Vitamin K antidote - Numerous medication interactions - Much longer half-life than heparin (days vs. hours)
32
Dabigatran
Direct thrombin inhibitor (Warfarin alternative) MOA: Directly inhibits actions of free and bound thrombin Indications: - Treatment of DVT/PE - Prevention of VTE in THA and TKA - Prevention of thrombosis in patients with atrial fibrillation Adverse Effects: - Bleeding - GI disturbances with dyspepsia and/or gastritis like s/s Nursing Considerations: - Don't crush or chew! - No need to monitor PT/INR! - Newly approved antidote: idarucizumab - Avoid aspirin, ibuprofen, or naproxen!
33
Rivaroxaban
Direct factor Xa inhibitor (similar to apixaban) MOA: Directly inhibits Xa and therefore, thrombin production Indications: - Treatment of DVT/PE - Prevention of VTE in THA and TKA - Prevention of thrombosis in patients with atrial fibrillation Adverse Effects: - Bleeding, especially with pre-existing renal impairment - Spinal/epidural hematoma Nursing Considerations: - Educate & monitor for signs of bleeding - No need to monitor PT/INR! - Caution with renal and/or hepatic impairment - Newly approved antidote: Andexxa
34
Alteplase
Thrombolytic MOA: forms complexes with plasminogen to convert into plasmin, an enzyme that digests fibrin, as well as degrade fibrinogen and other clotting factors Indications: - Acute MI, ischemic stroke, and PE - Low doses for blocked CVC (central venous cath) Adverse Effects: - Bleeding, particularly ICH (intracerebral hemorrhage) Nursing Considerations: - Many contraindications & precautions, obtain through history - Monitor closely for bleeding during administration & limit potential sources of bleeding - Efficacy seen if administered within 2-4 hours of symptom onset